Through with the flu: how free family and caregiver immunization protects sick neonates

Bryan L Burke1, Clare C Nesmith, Rachel E Ott

  • 1University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, AR 72005, USA. burkebryanl@uams.edu

Clinical Pediatrics
|December 26, 2009
PubMed

Insights

Newborns are highly vulnerable to the flu. A successful "cocoon" immunization program offered free vaccines to infant caregivers, protecting vulnerable infants before they are eligible for flu shots.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Newborn infants, particularly premature or chronically ill, face high risks of influenza-related complications.
  • Current influenza vaccines are not effective in infants younger than six months.
  • The cocoon immunization strategy aims to protect vulnerable infants by vaccinating their close contacts.

Purpose of the Study:

  • To describe the implementation and outcomes of a successful cocoon immunization program for newborns.
  • To evaluate the effectiveness of offering free influenza vaccines to household contacts of discharged infants.

Main Methods:

  • A program was established to provide free influenza vaccinations to family members and caregivers of discharged infants.
  • Vaccinations were administered in the nursery setting.
  • Program planning, implementation, and lessons learned were documented.

Main Results:

  • The program successfully immunized 185 contacts.
  • The response to the vaccination initiative exceeded expectations.
  • The program demonstrated the feasibility and success of the cocoon immunization theory.

Conclusions:

  • Cocoon immunization is an effective strategy to protect vulnerable newborns from influenza.
  • The program's success supports the expansion of similar initiatives nationwide.
  • Future plans include incorporating H1N1 and Tdap vaccines into the cocoon program.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...